Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the outcomes of radiofrequency ablation in the treatment of patients with malignant pulmonary nodules(not exceed 3cm )who are not suitable candidates for or ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chinese PLA General Hospital
NCT07287098 · Breast Neoplasms
NCT06487481 · Adrenocortical Carcinoma (ACC), Recurrent Adrenocortical Carcinoma (ACC), and more
NCT07585006 · Tobacco-Related Carcinoma, Addiction
NCT07321210 · Upper Tract Urothelial Carcinoma, Lymph Node Dissection
NCT07668037 · Non-Small Cell Carcinoma of Lung, Immunotherapy, and more
The Chinese PLA General Hospital
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions